Danielle Ann Merin

Fly with you soon ✨| Saved by Grace | fluctuat nec mergitur

[✮ndré @heyheyandre_art]

twitter being our online evacuation center is so correct

[gabitha. @igabitha]

you deserve someone with the same emotional maturity as you or at least someone trying their best to meet you there. to communicate. to learn you fully.

[Danielle Ann Merin @imDANIELLEmerin]

Leaving the bed is just the hardest thing to do when you’re not ready to face the day 🍂

[Danielle Ann Merin @imDANIELLEmerin]

@patriciafavis 2 consecutive nights eh?

[Danielle Ann Merin @imDANIELLEmerin]

Hi @CebuPacificAir, is it possible to transfer the baggage allowance from my Departure flight to my Return flight? Would highly appreciate your response on this. Thanks!

[Ayala Corporation @AyalaCorp_1834]

BREAKING: Molnupiravir arrives in the Philippines, the first in Southeast Asia, through MedEthix, JackPharma
#AyalaForPH
#ImprovingHealthcareForAll

Read more here: https://t.co/ZiH8YU6zI9

[Danielle Ann Merin @imDANIELLEmerin]

@kristinpeyyy reminiscing on those past days ❤️ haha everything seems nostalgic

[NewsWatch Plus PH @newswatchplusph]

Thirty-one hospitals and five drug companies got the green light to use and import molnupiravir, a game-changing drug against COVID-19.

We'll have an exchange with MedEthix Inc. CEO Monaliza Salian and Jackpharma Inc. President Meny Hernandez tonight with @RicoHizon.

[NewsWatch Plus PH @newswatchplusph]

MedEthix — the first local importer to secure a compassionate special permit (CSP) on behalf of the first four grantees for molnupiravir — says there would be enough doses for 300,000 patients coming in next month. https://t.co/DEwtX7LONd

[Manila Bulletin News @manilabulletin]

The first oral COVID-19 antiviral drug, Molnupiravir, will be available in the country next month, local importer MedEthix announced on Wednesday, Oct. 27.

https://t.co/93f4Xo58sO

[Kathleen de Villa @kdevillaINQ]

This initial delivery will cover about 300,000 patients to be availed through prescription in four hospitals earlier issued with a compassionate special permit by the Food and Drug Administration. @inquirerdotnet

[Kathleen de Villa @kdevillaINQ]

The first shipment of Molnupiravir, the first oral antiviral drug for COVID-19, will be brought next month by local importer MedEthix. @inquirerdotnet

[GMA News @gmanews]

Merck & Co’s experimental antiviral pill molnupiravir will be rolled out in the Philippines by November through hospitals with compassionate special permits (CSPs), Filipino company MedEthix said Wednesday.

https://t.co/DSoqnWMctD

[Carolyn Bonquin @CarolynBonquin]

FDA Dir. Domingo clarified that drugs under a CSP like molnupiravir didn’t go through their rigorous evaluation:
“This is a drug under clinical investigation…very encouraging ng result nya kaya maari humingi ang pasyente at Doctor ng special permit na madala rito ang gamot.”

[Carolyn Bonquin @CarolynBonquin]

Jackpharma Inc president Meneleo Hernandez said the estimated price per molnupiravir pill is at around P100-130. The recommended dosing regimen for molnupiravir is: 8 capsules/day for 5 days, as prescribed by doctor. @cnnphilippines

[Carolyn Bonquin @CarolynBonquin]

FDA Director Eric Domingo said 31 hospitals nationwide already secured a Compassionate Special Permit (CSP) to use molnupiravir to treat Covid-19 patients. MedEthix confirmed they will supply the pills to 4 hospitals with CSP. @cnnphilippines

[Carolyn Bonquin @CarolynBonquin]

MedEthix co-founder Monaliza Balnig Salian says anti-viral pill molnupiravir for 300,000 Covid-19 patients will be delivered to the country in November. These will be imported under a Compassionate Special Permit requested by 4 hospitals to the FDA last Sept. @cnnphilippines

[Kerwin King @imkerwinking]

Random waves of sadness are the worst